Adalimumab (HUMIRA®) is effective in treating patients with rheumatoid arthritis who previously failed infliximab treatment

被引：0
|
作者：
Van der Biji, AE
Breedveld, FC
Antoni, CE
Kalden, JR
Kary, S
Burmester, GR
Unnebrink, K
Kupper, H
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Univ Erlangen Nurnberg, Erlangen, Germany
[3] Charite Humbold Univ, Berlin, Germany
[4] Abbott GmbH Co KG, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：428 / +
页数：2
相关论文
共 50 条
  • [1] Adalimumab (HUMIRA®) is effective in treating patients with rheumatoid arthritis who previously failed etanercept and/or infliximab in real-life clinical settings.
    Bombardieri, S
    Tzioufas, AG
    McKenna, F
    Özer, Ü
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S144 - S144
  • [2] Efficacy and safety of adalimumab (HUMIRA®) in 899 patients with rheumatoid arthritis (RA) who previously failed etanercept and/or infliximab in clinical practice
    Bombardieri, S.
    McKenna, F.
    Drosos, A. A.
    Michel, B. A.
    Hartz, D.
    Oezer, U.
    Kupper, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 178 - 178
  • [3] Adalimumab (Humira) for the Treatment of Rheumatoid Arthritis
    Welch, Beth
    AMERICAN FAMILY PHYSICIAN, 2008, 78 (12) : 1406 - +
  • [4] Adalimumab (Humira) for rheumatoid arthritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1153): : 25 - 27
  • [5] Infliximab failures in rheumatoid arthritis can be successfully treated with adalimumab (Humira®)
    Van der Bijl, AE
    Breedveld, FC
    Antoni, C
    Kalden, JR
    Kary, S
    Burmester, GR
    Voss, B
    Kupper, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 264 - 264
  • [6] The cost utility of adalimumab (HUMIRA®) and infliximab (REMICADE) in the treatment of patients with early rheumatoid arthritis (RA):: US analysis
    Davies, AS
    Hutton, J
    Cifaldi, MA
    Pang, F
    Spencer-Green, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 393 - 393
  • [7] Secondary failure of adalimumab (Humira) in rheumatoid arthritis patients
    DeSilva, C.
    Mason, B.
    Kirkham, B.
    RHEUMATOLOGY, 2007, 46 : I30 - I30
  • [8] One-year efficacy of etanercept in rheumatoid arthritis patients who previously failed to infliximab.
    Gómez-Puerta, JA
    Rodriguez-Cros, J
    Graell, E
    Canete, JD
    Albaladejo, C
    Sanmartí, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S190 - S190
  • [9] A RESOURCE UTILISATION STUDY COMPARING HUMIRA™ (ADALIMUMAB) WITH REMICADE® (INFLIXIMAB) FOR THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS
    Hazleman, B.
    Ostor, A.
    Gurmin, V.
    Strickson, A.
    Pang, F.
    RHEUMATOLOGY, 2004, 43 : 79 - 79
  • [10] Humira - Adalimumab - Abbott Laboratories - New treatment for rheumatoid arthritis
    不详
    FORMULARY, 2003, 38 (02) : 78 - 79
12345